This month, the ANA talks with Jerome Graber, MD, MPH, an Associate Professor at the University of Washington who specializes in neuro-oncology. Dr. Graber discusses treatment options that improve quality of life for patients, his work with applications of neuroimaging, and more.

This month, the ANA speaks to Muhammad Alvi, MD, Assistant Professor, Medical Director of Stroke at J.W. Ruby Memorial Hospital, Berkeley Medical Center, WVU Rockefeller Neuroscience Institute. Dr. Alvi speaks about “silent strokes,” the use of Tenecteplase, and more.

This month, the ANA talks with this year’s recipient of the Distinguished Neurology Teacher Award, Ann Poncelet, MD, FAAN. Dr. Poncelet is the William G. Irwin Endowed Chair and Director of the Haile T. Debas Academy of Medical Educators at the University of California, San Francisco (UCSF), where she supports educators and the education mission at UCSF. Dr.

For this month’s ANA Member Highlight, we talk to Dr. Francesca Bagnato, MD, PhD, a dual-board neurology certified physician and faculty member at the Vanderbilt University Medical Center. Dr.

"It is exciting to witness numerous diverse and complementary efforts relying on genetic and pharmacological approaches to CMT. Some of these will surely bear fruit soon." ~ Dr. Florian P. Thomas

In conjunction with National Concussion Awareness Day and National Traumatic Brain Injury Awareness Month, the ANA talks with Ramon R. Diaz-Arrastia, MD, PhD, Director of the Traumatic Brain Injury Clinical Research Center at Penn Medicine in Philadelphia, Pennsylvania.

In this month’s ANA Q&A Membership Spotlight, we interviewed Beau M. Ances, MD, PhD, MSc who talks about the research that has gone into HIV medicine, cognitive issues for those who are HIV positive and getting older, and how his lab’s work can be used to study the COVID-19 virus.

For Alzheimer's and Brain Awareness Month, ANA interviewed Dr. Dongming Cai, an Associate Professor in the Department of Neurology at the Icahn School of Medicine at Mount Sinai and Staff Physician for James J. Peters VA Medical Center.

What does the public need to understand about Alzheimer's disease that it often doesn’t?

"We are currently undergoing a significant shift in the way in which we conduct clinical trials for the ALS population. Increasing recognition of cohort enrichment, where a more homogeneous treatment group is identified, is more evident today and greatly increases our ability to find effective treatments."